|
News For CAT;IQNT;GRMN;JCP;JNJ;KRC;NKTR;STRA;VRTX;VNO;BMY;PBR;HES From The Last 14 Days Check below for free stories on CAT;IQNT;GRMN;JCP;JNJ;KRC;NKTR;STRA;VRTX;VNO;BMY;PBR;HES the last two weeks. |
|
|
| May 22, 2013 |
| 10:33 EDT |  | BMY | Bristol-Myers jumps after Citi ups rating on cancer potential
 Subscribe for More Information |
|
| 10:16 EDT |  | BMY | Bristol-Myers spikes higher following upgrade, levels to watch
Subscribe for More Information |
|
| 10:00 EDT |  | BMY | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 09:42 EDT |  | CAT | Senate Committee on Foreign Relations to hold a hearing
The Committee holds a hearing entitled, "Different Perspectives on International Development" with Director of International Governmental Affairs Lane of Caterpillar (CAT) on May 22 at 10:30 am. Webcast Link |
|
| 06:05 EDT | | BMY | Bristol-Myers upgraded to Buy from Neutral at Citigroup
Subscribe for More Information |
|
| 06:01 EDT |  | HES | Hess Corp. implied volatility at lower end of index mean range
|
|
| May 21, 2013 |
| 10:22 EDT |  | CAT | Caterpillar to resume talks with steelworkers, WSJ says
Subscribe for More Information |
|
| 09:29 EDT | | NKTR | AstraZeneca says Phase III studies of Naloxegol met primary, secondary endpoints
AstraZeneca (AZN) presented the results of two pivotal Phase III studies of naloxegol showing the 25 mg dose of the investigational drug met its primary and secondary endpoints for efficacy and showed a safety profile consistent with previous studies. Data was presented at the Digestive Disease Week meeting in Orlando, Florida. The primary endpoint in both trials was percentage of OIC responders, versus placebo, over 12 weeks of treatment. The secondary endpoints included the 12-week response rate in a laxative inadequate response population, the median time to first spontaneous bowel movement and the number of days per-week with at least one bowel movement. Plans for naloxegol will be finalized over the coming months, incorporating the outcome of ongoing discussions with health authorities in the US, EU and Canada, the company said. Naloxegol, a peripherally-acting mu-opioid receptor antagonist, has been specifically designed for the treatment of opioid-induced constipation and is part of the exclusive worldwide license agreement announced on 21 September 2009, between AstraZeneca and Nektar Therapeutics (NKTR). |
|
| 08:56 EDT | | JCP | J.C. Penney announces successful tender, consent solicitation for debentures
Subscribe for More Information |
|
| 07:34 EDT | | BMY | UBS to host a conference
Subscribe for More Information |
| |
| 07:24 EDT | | JNJ, BMY | Global Health Care to host a conference
Subscribe for More Information |
|
| May 20, 2013 |
| 10:45 EDT |  | CAT | Caterpillar trends were weak in April, says Wells Fargo
Wells Fargo notes that Caterpillar's machines sales growth decelerated in April. The firm thinks that modest improvements in the company's overall trends may be mostly offset by North American machines sales deceleration, and it keeps a Market Perform rating on the shares. |
|
| 10:23 EDT | | JCP | J.C. Penney advances after analyst hikes price target to $27
Subscribe for More Information |
|
| 10:11 EDT | | JCP | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 10:03 EDT | | BMY | Shire advances after report renews takeover speculation
Subscribe for More Information |
|
| 09:03 EDT | | CAT | Caterpillar reports Power Systems retail down 5% in 3-months end April
Subscribe for More Information |
|
| 09:01 EDT | | CAT | Caterpillar reports April 3-month rolling period retail machine sales down 9%
Subscribe for More Information |
|
| 08:16 EDT | | JCP | Follow-up: J.C. Penney upgraded to Buy from Hold at Maxim
Maxim upgraded J.C. Penney on expectations the company's strategy changes under new CEO Mike Ullman will drive traffic. The firm said its recent channel checks indicate that store traffic has increased and it raised its price target for shares to $27 from $16.50. |
|
| 08:03 EDT | | JCP | J.C. Penney upgraded to Buy from Hold at Maxim
|
|
| 07:45 EDT | | CAT | Wunderlich Securities to hsot a summit
Subscribe for More Information |
| |
| 07:30 EDT | | JCP | J.C. Penney price target lowered to $7 from $12 at BMO Capital
Subscribe for More Information |
|
| 06:30 EDT | | BMY | Leerink estimates Shire takeout value at least $110 per share
Leerink says a takeover price for Shire (SHPG) would need to be at least $110 per share in order to get the company's board to consider a sale. The firm notes a Daily Mail report last night said Bristol-Myers (BMY) has engaged advisors to study an acquisition of Shire and that Shire's CEO has contacted bankers to consider anti-takeover measures. Leerink believes a Bristol-Myers takeover of Shire would make sense and keeps an Outperform rating on Shire. |
|
| 06:25 EDT | | BMY | Shire may return cash to thwart takeover, Daily Mail reports
Subscribe for More Information |
|
| 06:04 EDT | | IQNT | Neutral Tandem announces intention to declare special devidend of $1.25
The company also announced its intention to initiative a quarterly dividend of 6.25c per share. Both dividends are expected to be declared and paid within the next three months. |
|
| May 17, 2013 |
| 14:34 EDT | | PBR | Petrobras May volatility at low end of historic range
Subscribe for More Information |
|
| 13:21 EDT | | BMY | Options with increasing implied volatility: CPRT BMY GDI HNZ
Subscribe for More Information |
|
| 11:59 EDT | | HES | Options with decreasing implied volatility: ILMN LO A HES INFY CSCO
|
|
| 11:17 EDT | | IQNT | Ruckus Wireless volatility low, shares trend up on upgrade to Buy at Goldman
Ruckus Wireless June call option implied volatility is at 67, August is at 70, November is at 67; compared to its 20-week average of 73 according to Track Data, suggesting decreasing price movement. |
|
| 10:55 EDT | | JCP | J.C. Penney drops after results miss expectations
Subscribe for More Information |
|
| 10:36 EDT | | NKTR | Leerink's major/specialty pharma analyst holds analyst/Industry conference call
Subscribe for More Information |
| |
| 09:48 EDT | | JCP | J.C. Penney falls after earnings miss, levels to watch
Subscribe for More Information |
|
| 08:35 EDT | | JCP | J.C. Penney reiterated as a Sell at Northcoast
Subscribe for More Information |
|
| 07:47 EDT | | JCP | J.C. Penney situation should only improve from here, says RW Baird
Baird believes there are several reasons why J.C. Penney's situation should only improve from here including better recent trends, prudent pricing and promotion, easy comps, and the re-introduction of in-demand product for fall. Baird maintains its Neutral rating and $19 price target pending further details on the company's new strategy. |
|
| 07:11 EDT | | JCP | J.C. Penney CEO says needs time to fix problems, Reuters reports
J.C. Penney CEO Ullman says that the department store chain is emerging from what he called an abyss but warned he needs time to fix the issues of the retailer, reports Reuters.Reference Link |
|
| 06:28 EDT | | JCP | J.C. Penney CEO likely to make substantial progress, says Deutsche Bank
Subscribe for More Information |
|
| 06:19 EDT | | JNJ | J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
Subscribe for More Information |
|
| 06:06 EDT | | JCP | On the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: A so-so Q1 earnings season hasn't dented investors' enthusiasm for stocks as prices have been rising, with the DJIA up 16% for the year and 4.2% since earnings season began April 8, the Wall Street Journal reports...JPMorgan Chase (JPM), in a last-ditch effort to beat back activist investors, sent a letter to shareholders who have yet to vote on the nonbinding proposal ahead of the May 21 annual meeting, urging them to reject a proposal to split the chairman and CEO roles held by James Dimon, the Wall Street Journal reports...REUTERS: Amazon.com (AMZN) will be called back to the British parliament to clarify how its activities in the U.K. justify its low corporate income tax bill, Reuters reports...J.C. Penney (JCP) CEO Ullman says that the department store chain is emerging from what he called an abyss but warned he needs time to fix the issues of the retailer, Reuters reports...BLOOMBERG: Apple (AAPL), which holds $102B in cash and investments outside the U.S., will suggest changes to corporate-tax laws to encourage companies to bring more cash into the country, Bloomberg reports...Fiat’s (FIATY) deliberations over moving its headquarters to the U.S. after a merger with Chrysler Group LLC. raised concern among Italian unions and politicians about the plans of the country’s biggest manufacturer. CEO Marchionne is considering the move because Fiat’s main sources of revenue and profit are shifting to North America, Bloomberg reports. |
|
| 05:50 EDT | | JCP | J.C. Penney price target raised to $20 from $15 at Citigroup
Citigroup raised its price target for J.C. Penney to $20 following the company's Q1 results while keeping a Neutral rating on the stock. Citi says it is encouraged by new CEO Mike Ullman's strategic plan, which it expects will improve same-store-sales. |
|
| 05:21 EDT | | CAT | Caterpillar, Mining Machinery resolve all outstanding issues
Subscribe for More Information |
|
| May 16, 2013 |
| 19:01 EDT | | CAT | Caterpillar and Mining Machinery Limited announce settlement agreement
Subscribe for More Information |
| |
| 18:56 EDT | | JCP | On The Fly: After Hours Movers
UP AFTER EARNINGS: SINA (SINA), up 4.2%. ALSO HIGHER: Kansas City Southern (KSU), up 1.6% after it was announced the company would replace Dean Foods (DF) in the S&P 500 on May 23. DOWN AFTER EARNINGS: Autodesk (ADSK), down 6.5% after earnings, guiding its second quarter below expectations... Aruba Networks (ARUN), down 17.1% after earnings, guiding its fourth quarter below expectations... Nordstrom (JWN), down 3.5%... J.C. Penney (JCP), down 1.7%... Brocade (BRCD), down 2.4% after earnings, guiding its third quarter below expectations. |
|
| 18:03 EDT | | JCP | J.C. Penney says Q1 traffic down 6% vs. year ago
Subscribe for More Information |
|
| 16:42 EDT | | JCP | J.C. Penney down 30c, or 1.60%, to $18.49 after earnings miss estimates
|
|
| 16:37 EDT | | JCP | J.C. Penney reports Q1 gross margin 30.8% of sales vs. 37.6% a year ago
Subscribe for More Information |
|
| 16:32 EDT | | BMY | Bristol-Myers announces intention to voluntarily delist preferred stock
Subscribe for More Information |
|
| 16:31 EDT |  | JCP | J.C. Penney reports Q1 adjusted EPS ($1.31), consensus (86c)
Subscribe for More Information |
|
| 15:14 EDT | | JCP | Notable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Dell (DELL), consensus 35c; Applied Materials (AMAT), consensus 13c; Nordstrom (JWN), consensus 76c; Autodesk (ADSK), consensus 45c; J. C. Penney (JCP), consensus (86c); SINA (SINA), consensus (3c); ViaSat (VSAT), consensus 2c; Brocade Communications (BRCD), consensus 15c; Aruba Networks (ARUN), consensus 15c. |
|
| 13:52 EDT | | JCP | J.C. Penny May 19 straddle priced for 8% move into Q1
|
|
| 13:45 EDT | | GRMN | iSuppli: 250M sports, fitness monitors to ship in next five years
Subscribe for More Information |
|
| 13:36 EDT | | HES | Hess Corp. names three Elliott nominees to board
Hess Corporation announced voting results from its annual meeting of stockholders. Pursuant to the agreement between the company and Elliott Management, Elliott withdrew prior to the annual meeting all five of its nominees, and agreed to support the election of the Hess slate of five nominees. The board of directors also appointed three Elliott nominees to the board: Rodney Chase, Harvey Golub, and David McManus. |
| |
| 13:20 EDT | | BMY | Follow-up: Bristol-Myers upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Bristol-Myers citing the company's multi-billion dollar immuno-oncology prospects. The firm says there were additional responses reported in the press briefing with combination nivolumab and Yervoy. Leerink has a $51 price target for shares. |
|
| 13:14 EDT | | BMY | Bristol-Myers upgraded to Outperform from Market Perform at Leerink
Subscribe for More Information |
|
| 11:40 EDT | | JCP | Stocks with call strike movement; FSLR JCP
Subscribe for More Information |
|
| 10:58 EDT | | HES | Hess Corp. mentioned positively at Deutsche Bank
Subscribe for More Information |
|
| 09:19 EDT | | HES | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 08:55 EDT | | BMY | BofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call
Subscribe for More Information |
|
| 08:38 EDT | | BMY | Bristol-Myers shares likely to give back recent gains, says Leerink
Leerink expects shares of Bristol-Myers to give back recent gains after ASCO published abstracts last night. The firm found the abstracts as in-line with, but not above, its expectations for nivolumab alone or immuno-oncology combination therapy and keeps a Market Perform rating on Bristol-Myers. |
|
| 08:34 EDT | | HES | Hess Corp., Elliot end proxy contest, three Elliot nominees to join board
Subscribe for More Information |
|
| 08:28 EDT | | HES | Hess Corp. to appoint three Elliott nominees to board, CNBC says
Subscribe for More Information |
|
| 08:00 EDT | | JCP | J.C. Penney shares more expensive than they look, says Wells Fargo
Although J.C. Penney's market cap is $4.2B, its enterprise value, including its net debt, is $7.4B, according to Wells Fargo. That is very similar to 2010 levels, when the retailer's EPS was $1.38, according to the firm. Wells notes that the stock would be trading at 15.1 times earnings even if the company generates $1.26 in EPS sometime in the future, and it keeps an Underperform rating on the shares. |
| |
| 05:52 EDT | | BMY | Stocks with implied volatility movement; BMY SLV
Subscribe for More Information |
|
| May 15, 2013 |
| 17:36 EDT | | HES | Paulson gives quarterly update on stakes
Subscribe for More Information |
|
| 17:09 EDT | | HES | Greenlight gives quarterly update on stakes
NEW STAKES: Oil States International (OIS), Hess (HES), Spirit (SPR), IAC/InterActiveCorp (IACI), and Capital Bank (CBF). INCREASED STAKES: Apple (AAPL). DECREASED STAKES: Microsoft (MSFT), Seagate (STX), Delphi (DLPH), CBS (CBS), and Computer Sciences (CSC). LIQUIDATED STAKES: Ensco (ESV), Xerox (XRX), Yahoo (YHOO), NVR (NVR), and Google (GOOG). |
|
| 16:51 EDT | | JNJ | FDA approves Simponi to treat ulcerative colitis
Subscribe for More Information |
|
| 12:29 EDT | | HES | Hess Corp. removed from U.S. 1 List at BofA/Merrill
|
|
| 11:48 EDT | | HES | Appaloosa reports new stakes in Comcast, Ashland, sells Oracle
David Tepper's Appaloosa in its quarterly filing report new positions in Comcast (CMCSA), Prudential (PRU), Hess Corp. (HES), Check Point (CHKP), KBR (KBR) and Ashland (ASH). The fund sold its stakes in Oracle (ORCL) and Noble Corp. (NE). Appaloosa's top position is in Citigroup (C), with a stake worth over $376.9M. |
|
| 11:45 EDT | | JCP | Stocks with call strike movement; JCP BBY
Subscribe for More Information |
|
| 11:28 EDT | | BMY | Options with increasing implied volatility: BMY AGNC EBIX IAU
Subscribe for More Information |
|
| 09:43 EDT | | BMY | Active equity option families trading on open
Subscribe for More Information |
|
| 08:48 EDT | | JCP | J.C. Penney recommended at Buckingham
Subscribe for More Information |
| |
| 05:56 EDT | | JCP | J.C. Penney board supporting new CEO, not Ackman, NY Post reports
Bill Ackman has lost influence over J.C. Penney's (JCP) board after failing to quickly replace the company's new CEO Mike Ullman, New York Post reports, citing sources. Ackman approached a number of candidates about the position, including Foot Locker (FL) CEO Ken Hicks, but the board was not interested, the paper adds. Reference Link |
|
| May 14, 2013 |
| 16:24 EDT | | JCP | J.C. Penney real estate appraised at $4.06B, Reuters says
Subscribe for More Information |
|
| 15:29 EDT | | JCP | J.C. Penney stores, real estate appraised at $4.06B, Reuters reports
|
|
| 15:13 EDT | | JCP | J.C. Penny May 19 straddle priced for 8.5% move into Q1
Subscribe for More Information |
|
| 14:37 EDT | | PBR | Petrobras 'in no hurry' to decide on offer for Argentine unit, Reuters says
Petrobras president Maria das Gracas Foster said Argentine companies have made an offer to buy some of the assets it has put up for sale, but added that Petrobras is in no hurry and has not made a decision, according to Reuters, citing Foster's comments in a Senate economic affairs hearing. Reference Link |
|
| 14:12 EDT | | JCP | J.C. Penney upgraded to Neutral from Underperform at BofA/Merrill
Subscribe for More Information |
|
| 11:51 EDT | | JCP | Stocks with call strike movement; JCP BBY
J.C. Penney (JCP) June 21 call volatility increased 2% to 60, Best Buy (BBY) June 31 call option implied volatility decreased 2% to 59 according to IVolatility. |
|
| 09:12 EDT | | JCP | J.C. Penney increases tender offer consideration to $1,400
Subscribe for More Information |
|
| 07:24 EDT | | BMY | EBD Group to host a conference
BioTrinity 2013 is being held in Newbury, England on May 14-16. |
|
| May 13, 2013 |
| 17:50 EDT | | HES | Elliott calls Hess statement 'PR stunt', wants all of its candidates on board
Subscribe for More Information |
| |
| 16:42 EDT | | HES | Hess commits to adding Elliott nominees if five new independent nominees elected
Subscribe for More Information |
|
| 11:30 EDT | | JCP | J.C. Penney May volatility elevated at 96 into Q1
Subscribe for More Information |
|
| 09:50 EDT | | JCP | J.C. Penney pops higher in early trading, levels to watch
Subscribe for More Information |
|
| 09:11 EDT | | JCP | J.C. Penney feedback indicates a sales pickup, sa Cleveland Research
Subscribe for More Information |
|
| 08:45 EDT | | PBR | Petrobras plans six-tranche sale of dollar bonds abroad, Bloomberg reports
Petroleos Brasileiros (PBR) plans to sell dollar bonds abroad in the company’s first overseas offering since February 2012, reports Bloomberg. The state-run oil producer wants to sell fixed-rate bonds due in three, five, 10 and 30 years as well as three- and five-year floating-rate bonds, sources say. t Reference Link |
|
| 06:33 EDT | | HES | Hess's five independent nominees waive rights to payments in compensation plan
Subscribe for More Information |
|
| May 10, 2013 |
| 14:02 EDT | | VRTX | Vertex to benefit from Welsh government decision, says Wells Fargo
Subscribe for More Information |
|
| 13:26 EDT | | JCP | S&P assigns J.C. Penney term loan 'B' issue-level rating
Subscribe for More Information |
|
| 11:48 EDT | | JNJ, BMY | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| 10:37 EDT | | NKTR | Nektar shares should be bought on weakness, says MKM Partners
Subscribe for More Information |
| |
| 10:01 EDT | | STRA | House GOP proposes reform of student loan interest rates, The Hill says
Subscribe for More Information |
|
| 10:00 EDT |  | JCP | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 09:50 EDT | | HES | Elliott says Hess split of Chairman, CEO roles 'not a concession or step'
Elliott Management, one of the largest shareholders of Hess Corporation, issued a statement on the Hess announcement regarding separation of the chairman and chief executive officer roles: “A resolution to split the Chairman & CEO roles at Hess is on this year’s proxy. Hess’s announcement today is not a concession or step on the part of the Company, rather it is a reaction to the shareholder vote currently underway. It is significant to note that Hess’s Board recommended against this split only a few weeks ago." |
|
| 07:25 EDT | | JCP | J.C. Penney downgraded to Sell from Neutral at Northcoast
Subscribe for More Information |
|
| 07:02 EDT | | HES | Hess Corp. to separate Chairman and CEO roles
Subscribe for More Information |
|
| 07:00 EDT | | HES | Hess Corp. to separate Chairman and CEO roles
|
|
| 06:30 EDT | | CAT | Caterpillar, Milwaukee workers' union talks suspended, Reuters says
Subscribe for More Information |
|
| 06:16 EDT | | JNJ | Obesity surgery booming in India, Bloomberg reports
Subscribe for More Information |
|
| May 9, 2013 |
| 17:09 EDT | | JNJ | Johnson & Johnson deal to settle sales practices probe stalls, WSJ reports
Johnson & Johnson's $2.2B settlement with the Justice Department related to its promotion of certain drugs is on hold as the company is looking to avoid language in the agreement that could make it vulnerable to private lawsuits, reports The Wall Street Journal, citing people familiar with the talks. Reference Link |
|
| 16:26 EDT | | NKTR | Nektar reports Q1 EPS (48c), consensus (42c)
Subscribe for More Information |
| |
| 10:17 EDT | | BMY | Shire trades higher in London amid takeover chatter, Guardian says
Subscribe for More Information |
|
| 09:51 EDT | | JNJ | J&J unit says first patient enrolled in reMARQable study
Subscribe for More Information |
|
| May 8, 2013 |
| 17:01 EDT |  | JCP | On The Fly: Closing Wrap
Stocks on Wall Street were higher again, pushing the Dow and S&P to new record levels. A late afternoon move down to the flatline made it seem like the recent winning streak was set to end, but the averages quickly reversed higher and closed firmly in positive ground. ECONOMIC EVENTS: In the U.S., the light economic calendar included MBA's report on mortgage applications, which were up 7%, and the EIA's petroleum status report, which showed crude oil inventories built up by less than was expected last week. In Europe, German industrial production increased 1.2% month-over-month in March, beating expectations for a 0.1% decline. In Asia, Chinese trade data showed exports climbed 14.7% in April, while imports were up 16.8%. However, some analysts expressed caution that the strong export gains should be viewed with some level of skepticism. COMPANY NEWS: Dow member Disney (DIS) beat expectations on the top and bottom line and price targets on the stock were raised at several firms, but shares slid 8c, or 0.12%, to $65.99... J.C. Penney (JCP) released preliminary Q1 results last night, including comparable store sales that were down 16.6% and revenue of $2.64B, which was below expectations. However, the results were enough to send shares of the heavily-shorted retailer up $1.21, or 7.38%, to $17.61. MAJOR MOVERS: Among the notable gainers was Whole Foods Market (WFM), up $9.39, or 10.12%, to $102.19 after earnings beat estimates, the company raised its full year outlook and announced a two-for-one stock split. Also higher were shares of Dex Media (DXM), up $2.84, or 20.71%, to $16.55 after Kyle Bass, presenting at the Sohn Investing Conference, said the company's stock could trade up to 5 times higher than current levels in 3 years. Among the noteworthy losers was Fusion-io (FIO), down $3.40, or 18.89%, to $14.60 after its CEO and chief marketing officer resigned and shares were downgraded by at least two analyst firms. Also lower following its earnings report was Zillow (Z), which fell $6.26, or 9.95%, to $56.68. INDICES: The Dow was up 48.92, or 0.32%, to 15,105.12; the Nasdaq was up 16.64, or 0.49%, to 3,413.27; and the S&P 500 was up 6.73, or 0.41%, to 1,632.69. |
|
| 13:59 EDT | | STRA | For-profit education stocks rally after Grand Canyon results
Subscribe for More Information |
|
| 12:20 EDT | | JCP | On The Fly: Midday Wrap
Subscribe for More Information |
|
| 12:11 EDT | | JCP | Stocks with call strike movement; FSLR JCP
Subscribe for More Information |
|
| 11:43 EDT | | CAT | Caterpillar sees some 'encouraging signs' in China business
Subscribe for More Information |
|
| 10:33 EDT | | BMY | Bristol-Myers, Pfizer announced results from ARISTOTLE trial subanalysis
Bristol-Myers (BMY) and Pfizer (PFE) announced yesterday that results from a prespecified subanalysis of the ARISTOTLE trial were published in Circulation, the peer-reviewed journal of the American Heart Association. Results from the subanalysis showed that the reductions in stroke or systemic embolism, number of major bleeding events and mortality demonstrated with Eliquis compared to warfarin in the ARISTOTLE trial were consistent across subgroups defined based on levels of International Normalized Ratio control in patients with nonvalvular atrial fibrillation. This story corrects a headline from yesterday. |
|
| 10:00 EDT | | JCP | On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Ametek (AME) upgraded to Buy from Neutral at Citigroup... IAMGOLD (IAG) upgraded to Buy from Hold at Canaccord... Lowe's (LOW) upgraded to Buy from Neutral at ISI Group... lululemon (LULU) upgraded to Buy from Neutral at Sterne Agee... Myriad Genetics (MYGN) upgraded to Buy from Neutral at Mizuho... Orion Marine (ORN) upgraded to Outperform from Market Perform at FBR Capital... Trex Company (TREX) upgraded to Buy from Hold at BB&T... U.S. Auto Parts (PRTS) upgraded to Buy from Neutral at Roth Capital... Electronic Arts (EA) upgraded to Neutral from Sell at Monness Crespi... Electro Scientific (ESIO) upgraded to Buy from Hold at Noble Financial... Darling (DAR) upgraded to Buy from Hold at Maxim... J.C. Penney (JCP) upgraded to Hold from Sell at Maxim... Louisiana-Pacific (LPX) upgraded to Neutral from Underperform at DA Davidson... Grupo Televisa (TV) upgraded to Overweight from Equal Weight at Morgan Stanley... Marathon Oil (MRO) upgraded to Outperform from Neutral at Macquarie... Sibanye Gold (SBGL) upgraded to Overweight from Neutral at JPMorgan... Carrols Restaurant (TAST) upgraded to Strong Buy from Outperform at Raymond James. |
|
| 09:25 EDT | | JCP | J.C. Penney could generate signficant profits by 2016, says Buckingham
Subscribe for More Information |
| |
| 08:57 EDT | | JCP | Follow-up: J.C. Penney upgraded to Hold from Sell at Maxim
Subscribe for More Information |
|
| 08:45 EDT | | JCP | J.C. Penney upgraded to Hold from Sell at Maxim
Subscribe for More Information |
|
| 08:33 EDT | | JCP | J.C. Penney estimates lowered on Q1 sales decline at Morgan Stanley
Subscribe for More Information |
|
| 07:38 EDT | | JNJ | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
|
|
|
|
